BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 16, 2018
View Archived Issues
Messenger RNA can treat porphyria
Read More
Neurons can switch transmitter allegiance in vivo
Read More
Astellas Cathespin S inhibitors prolong graft survival in a mouse cardiac transplant model
Read More
Targeted cancer therapy leads to twist of cell fate
Read More
Brigham Young University patents therapeutic bacteriophages
Read More
[18F]FC-303, an 18F-labeled PSMA radiotracer for PET imaging of prostate cancer
Read More
Shanghai De Novo Pharmatech identifies Wee1-like protein kinase inhibitors
Read More
Hefei Amvite Pharmaceutical and collaborators identify platelet adhesion inhibitors
Read More
SQZ Biotech expands cellular therapy partnership with Roche
Read More
Phase I/II study of KB-103 meets all primary efficacy and safety endpoints at interim data analysis
Read More
Soligenix receives recommendation to continue phase III FLASH study of SGX-301
Read More
TherapyX and Intravacc partner to develop Ngoxim prophylactic vaccine against gonorrhea
Read More
Cellect reports promising data from phase I/II study of ApoGraft technology
Read More
Dupixent reduces nasal polyp size and nasal congestion severity in phase III trials
Read More
[18F]HTK-01174 shows promise for PET imaging of prostate cancer
Read More
BARDA funding to support pediatric studies of Stratagraft for thermal burns
Read More
NIH grant supports Allele's development of nanoantibodies to treat sepsis
Read More
Praliciguat shows promise in phase IIa study in patients with type 2 diabetes and hypertension
Read More
Studies evaluate autologous tolerogenic dendritic cells in multiple sclerosis patients
Read More
ADAMTS7 as indicator of early left ventricular diastolic and systolic dysfunction in type 2 diabetes
Read More
VenatoRx presents pharmacokinetic and safety data for VNRX-5133
Read More
Inherited polymorphisms contribute to increased risk for Waldenstrom macroglobulinemia
Read More
Liposome adjuvant increases the immunogenicity of malaria vaccines
Read More
OncoSec initiates KEYNOTE-890 phase II study of Tavo plus Keytruda for TNBC
Read More
Athenex reports initial pilot results for T-cell receptor affinity enhancing specific T-cell therapy
Read More
Restorbio reports additional phase IIb data on RTB-101
Read More
FDA clears IND for phase I trial of CK-0801 in treatment-resistant Guillain-Barre syndrome
Read More
Axsome to develop AXS-12 for narcolepsy
Read More